Shares of AEHR are declining approximately 9.00% in Monday's session on April 27, 2026, falling from a prior close of $95.91 to approximately $87.28, as the market continues to digest mixed Q3 fiscal 2026 earnings results released after the close on April 25 while a broad AI semiconductor sector selloff adds incremental macro pressure.
Shares of LPTH are declining approximately 16.00% in Monday's session on April 27, 2026, falling from a prior close of $16.09 to approximately $13.52, as the stock breaks below its 5-day simple moving average in a technically triggered selloff compounded by broad market weakness across small-cap defense and optics names.
Shares of MXL are declining approximately 13.00% in Monday's session on April 27, 2026, falling from a prior close of $59.70 to approximately $51.94, as the explosive post-earnings momentum that drove an extraordinary ~80% surge on April 23 gives way to systematic profit-taking and valuation skepticism entering the new trading week.
Shares of CRDO are declining approximately 9.00% in Monday's early session on April 27, 2026, falling from a prior close of $195.04 to approximately $177.49, in a sector-driven selloff that is pulling high-beta AI semiconductor names sharply lower at the start of the new trading week.
Shares of VELO are declining approximately 18.00% in Monday's session on April 27, 2026, falling from a prior close of $17.36 to approximately $14.24, as the momentum that drove an extraordinary 38% single-session surge on April 20 fully reverses against a backdrop of no incremental positive catalyst to justify the elevated price level entering the new trading week.
Analysts expect Q1 2026 EPS of $2.06, building on Q4 2025's adjusted EPS beat of $2.14 versus $2.05 estimates. Consensus revenue forecast stands at approximately $22.97 billion, reflecting about 10% year-over-year growth.
Analysts forecast Q1 2026 revenue of approximately $13.6 billion, a modest 2.5% increase year-over-year. Consensus EPS estimate stands at $2.11 per share, reflecting steady profitability.
Consensus estimates call for First Quarter 2026 EPS (earnings per share) of $0.81, up from comparable $0.73 in Q1 2025. Analysts project net revenues of $12.28 billion, representing roughly 10% year-over-year growth from $11.1 billion.
Analysts project fiscal second quarter 2026 revenue of $10.7 billion, representing 11.5% year-over-year growth. Consensus earnings per share (EPS) stands at $3.09, implying roughly 12% growth from the prior year.
MRVL shares are declining approximately 5% in Monday's session, pulling back from a 52-week high of $170.84 reached earlier in the day toward the $164 range. The primary driver is a sector-wide AI and semiconductor selloff, with bellwether peer ARM plunging over 10% in the same session, pulling the broader chip complex lower.
DPZ shares are falling approximately 10% in Monday's session, trading near $331 from a prior close of $368.18 on April 24, 2026. The primary catalyst is a disappointing Q1 2026 earnings report, with both revenue and EPS coming in below analyst expectations.
ARM shares are declining approximately 10% in Monday's session, retreating to roughly $211.33 from a prior close of $234.81 on April 24, 2026. The primary driver is aggressive profit-taking following a near-70% price rally over just one month — from $136.96 on March 30 to $234.81 by April 24.
CMPX shares are plunging approximately 62% in Monday's session, collapsing to roughly $1.98 from a prior close of $5.21 on April 24, 2026. The primary catalyst is the presentation of topline secondary endpoint data from the Phase 2/3 COMPANION-002 trial of tovecimig (CTX-009) plus paclitaxel in advanced biliary tract cancer, widely interpreted as disappointing.
AAOI shares are declining approximately 12% in Monday's session, pulling back to roughly $142.71 from a prior close of $162.17 on April 24, 2026. The drop is primarily driven by aggressive profit-taking following Friday's 17.74% single-session surge.
POET shares are plunging approximately 42% in Monday's premarket session, falling to around $8.76 after closing at $15.10 on April 24, 2026. The selloff represents a sharp mean-reversion following a stunning 108% weekly rally driven by confirmed supply orders within Marvell Technology's AI ecosystem.
Vent​as is slated to release its fiscal Q1 2026 results on April 27, 2026, after the NYSE close. Consensus expectations call for $1.66 billion in revenue (+16.6% YoY) and earnings per share (EPS) of $0.12.
Celestica Inc. ( CLS ) follows a calendar fiscal year that ends on December 31, so its first quarter of 2026 (Q1 2026) covers January‑March 2026. The company closed Q4 2025 on a strong note, posting $3.65 billion in revenue and $1.89 in adjusted EPS, and used that momentum to raise its full‑year outlook. This earnings window is critical because Celestica is positioning itself as a key supplier of AI‑related data‑center hardware – a segment that’s expanding quickly as hyperscalers increase AI workloads. Investors are therefore focused on how quickly the new capacity can be turned into commercial orders and whether margins can keep improving.
Nucor Corporation (NYSE: NUE ) is North America’s largest steel recycler and a leading vertically integrated steel producer. The upcoming first‑quarter 2026 earnings are critical because they will indicate whether the company can sustain the margin expansion seen after a robust fourth‑quarter 2025 rebound. Steel demand remains closely tied to non‑residential construction and infrastructure spending, both of which are receiving renewed policy attention. Investors also keep an eye on Nucor’s capital‑return strategy—share buybacks and dividend payouts—as a gauge of confidence in cash generation.
Analysts forecast Q1 2026 revenue of approximately $1.21 billion, a modest year‑over‑year increase. Projected earnings per share (EPS) are $2.42, reflecting continued profitability despite higher operating costs.
Cadence Design Systems ( CDNS ) leads the electronic design automation (EDA) space with a portfolio that spans software, hardware platforms, and semiconductor IP. The upcoming first‑quarter 2026 results are a critical checkpoint to see if the demand for its AI‑driven design solutions can sustain the momentum built in a record‑setting 2025. Investors are also focused on whether Cadence can keep its high‑margin mix and convert a $7.8 billion backlog into near‑term revenue growth.
Previous
77 of 509
Next